U.S. markets closed

Wave Life Sciences Ltd. (WVE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
7.99-0.32 (-3.85%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close8.31
Open8.31
Bid7.97 x 1000
Ask8.35 x 2200
Day's Range7.92 - 8.35
52 Week Range6.61 - 39.98
Volume674,866
Avg. Volume1,180,436
Market Cap387.241M
Beta (5Y Monthly)0.32
PE Ratio (TTM)N/A
EPS (TTM)-5.66
Earnings DateAug 10, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est17.71
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Benzinga

    Benzinga's Top Upgrades, Downgrades For October 23, 2020

    Upgrades * For Mattel Inc (NASDAQ: MAT), DA Davidson upgraded the previous rating of Neutral to the current rating Buy. In the third quarter, Mattel showed an EPS of $0.95, compared to $0.26 from the year-ago quarter. The stock has a 52-week-high of 14.83 and a 52-week-low of 6.53. At the end of the last trading period, Mattel closed at $12.92. * For Spire Inc (NYSE: SR), Credit Suisse upgraded the previous rating of Neutral to the current rating Outperform. Spire earned $0.07 in the third quarter, compared to $0.07 in the year-ago quarter. The current stock performance of Spire shows a 52-week-high of 87.96 and a 52-week-low of 50.58. Moreover, at the end of the last trading period, the closing price was at $58.24. * According to Stephens & Co., the prior rating for Stewart Information Services Corp (NYSE: STC) was changed from Equal-Weight to Overweight. For the third quarter, Stewart Information Servs had an EPS of $2.21, compared to year-ago quarter EPS of $1.28. The current stock performance of Stewart Information Servs shows a 52-week-high of 49.48 and a 52-week-low of 20.26. Moreover, at the end of the last trading period, the closing price was at $42.10. * Susquehanna upgraded the previous rating for StoneCo Ltd (NASDAQ: STNE) from Neutral to Positive. In the second quarter, StoneCo showed an EPS of $0.10, compared to $0.16 from the year-ago quarter. The current stock performance of StoneCo shows a 52-week-high of 60.76 and a 52-week-low of 17.72. Moreover, at the end of the last trading period, the closing price was at $57.88. * Susquehanna upgraded the previous rating for PulteGroup Inc (NYSE: PHM) from Neutral to Positive. In the third quarter, PulteGroup showed an EPS of $1.34, compared to $1.01 from the year-ago quarter. The current stock performance of PulteGroup shows a 52-week-high of 49.7 and a 52-week-low of 17.12. Moreover, at the end of the last trading period, the closing price was at $42.65. * MKM Partners upgraded the previous rating for Motorola Solutions Inc (NYSE: MSI) from Neutral to Buy. In the second quarter, Motorola Solutions showed an EPS of $1.39, compared to $1.69 from the year-ago quarter. The current stock performance of Motorola Solutions shows a 52-week-high of 187.49 and a 52-week-low of 120.77. Moreover, at the end of the last trading period, the closing price was at $168.99. * Benchmark upgraded the previous rating for Seagate Technology PLC (NASDAQ: STX) from Hold to Buy. Seagate Technology earned $0.93 in the first quarter, compared to $1.03 in the year-ago quarter. The stock has a 52-week-high of 64.17 and a 52-week-low of 39.02. At the end of the last trading period, Seagate Technology closed at $51.79. * For TRI Pointe Group Inc (NYSE: TPH), B. Riley FBR upgraded the previous rating of Neutral to the current rating Buy. In the third quarter, TRI Pointe Group showed an EPS of $0.63, compared to $0.44 from the year-ago quarter. The stock has a 52-week-high of 19.59 and a 52-week-low of 5.89. At the end of the last trading period, TRI Pointe Group closed at $16.79. * JMP Securities upgraded the previous rating for Redwood Trust Inc (NYSE: RWT) from Market Perform to Market Outperform. In the second quarter, Redwood Trust showed an EPS of $1.00, compared to $0.39 from the year-ago quarter. At the moment, the stock has a 52-week-high of 18.01 and a 52-week-low of 2.14. Redwood Trust closed at $8.35 at the end of the last trading period. * RBC Capital upgraded the previous rating for PulteGroup Inc (NYSE: PHM) from Sector Perform to Outperform. In the third quarter, PulteGroup showed an EPS of $1.34, compared to $1.01 from the year-ago quarter. The current stock performance of PulteGroup shows a 52-week-high of 49.7 and a 52-week-low of 17.12. Moreover, at the end of the last trading period, the closing price was at $42.65. * According to RBC Capital, the prior rating for Whirlpool Corp (NYSE: WHR) was changed from Underperform to Sector Perform. For the third quarter, Whirlpool had an EPS of $6.91, compared to year-ago quarter EPS of $3.97. The current stock performance of Whirlpool shows a 52-week-high of 207.3 and a 52-week-low of 64.0. Moreover, at the end of the last trading period, the closing price was at $193.77. * According to Piper Sandler, the prior rating for EOG Resources Inc (NYSE: EOG) was changed from Neutral to Overweight. For the second quarter, EOG Resources had an EPS of $0.23, compared to year-ago quarter EPS of $1.31. The current stock performance of EOG Resources shows a 52-week-high of 89.54 and a 52-week-low of 27.0001. Moreover, at the end of the last trading period, the closing price was at $36.92. * Piper Sandler upgraded the previous rating for Pioneer Natural Resources Co (NYSE: PXD) from Neutral to Overweight. For the second quarter, Pioneer Natural Resources had an EPS of $0.32, compared to year-ago quarter EPS of $2.01. The stock has a 52-week-high of 159.01 and a 52-week-low of 48.62. At the end of the last trading period, Pioneer Natural Resources closed at $83.02. Downgrades * For The Kroger Co (NYSE: KR), Evercore ISI Group downgraded the previous rating of Outperform to the current rating In-Line. For the second quarter, Kroger had an EPS of $0.73, compared to year-ago quarter EPS of $0.44. The current stock performance of Kroger shows a 52-week-high of 37.22 and a 52-week-low of 24.09. Moreover, at the end of the last trading period, the closing price was at $32.64. * Keefe, Bruyette & Woods downgraded the previous rating for Wintrust Financial Corp (NASDAQ: WTFC) from Outperform to Market Perform. Wintrust Financial earned $1.67 in the third quarter, compared to $1.69 in the year-ago quarter. At the moment, the stock has a 52-week-high of 71.95 and a 52-week-low of 22.0215. Wintrust Financial closed at $50.34 at the end of the last trading period. * JP Morgan downgraded the previous rating for TAL Education Group (NYSE: TAL) from Overweight to Neutral. In the second quarter, TAL Education showed an EPS of $0.08, compared to $0.02 from the year-ago quarter. The stock has a 52-week-high of 83.675 and a 52-week-low of 36.12. At the end of the last trading period, TAL Education closed at $66.30. * According to Jefferies, the prior rating for Navistar International Corp (NYSE: NAV) was changed from Buy to Hold. Navistar International earned $0.08 in the third quarter, compared to $1.47 in the year-ago quarter. The stock has a 52-week-high of 45.25 and a 52-week-low of 15.01. At the end of the last trading period, Navistar International closed at $43.12. * For Citrix Systems Inc (NASDAQ: CTXS), Morgan Stanley downgraded the previous rating of Overweight to the current rating Equal-Weight. Citrix Systems earned $1.38 in the third quarter, compared to $1.52 in the year-ago quarter. The current stock performance of Citrix Systems shows a 52-week-high of 173.56 and a 52-week-low of 100.31. Moreover, at the end of the last trading period, the closing price was at $126.65. Initiations * With a current rating of Buy, Truist Securities initiated coverage on Pfizer Inc (NYSE: PFE). The price target seems to have been set at $42.00 for Pfizer. Pfizer earned $0.78 in the second quarter, compared to $0.80 in the year-ago quarter. At the moment, the stock has a 52-week-high of 40.97 and a 52-week-low of 27.88. Pfizer closed at $37.46 at the end of the last trading period. * Truist Securities initiated coverage on Merck & Co Inc (NYSE: MRK) with a Buy rating. The price target for Merck & Co is set to $96.00. In the second quarter, Merck & Co showed an EPS of $1.37, compared to $1.30 from the year-ago quarter. At the moment, the stock has a 52-week-high of 92.64 and a 52-week-low of 65.25. Merck & Co closed at $79.20 at the end of the last trading period. * Truist Securities initiated coverage on Eli Lilly and Co (NYSE: LLY) with a Buy rating. The price target for Eli Lilly is set to $180.00. Eli Lilly earned $1.89 in the second quarter, compared to $1.50 in the year-ago quarter. At the moment, the stock has a 52-week-high of 170.75 and a 52-week-low of 101.36. Eli Lilly closed at $141.59 at the end of the last trading period. * Truist Securities initiated coverage on Bristol-Myers Squibb Company (NYSE: BMY) with a Hold rating. The price target for Bristol-Myers Squibb is set to $65.00. Bristol-Myers Squibb earned $1.63 in the second quarter, compared to $1.18 in the year-ago quarter. At the moment, the stock has a 52-week-high of 68.34 and a 52-week-low of 45.76. Bristol-Myers Squibb closed at $60.76 at the end of the last trading period. * With a current rating of Buy, Truist Securities initiated coverage on AbbVie Inc (NYSE: ABBV). The price target seems to have been set at $110.00 for AbbVie. AbbVie earned $2.34 in the second quarter, compared to $2.26 in the year-ago quarter. The current stock performance of AbbVie shows a 52-week-high of 101.28 and a 52-week-low of 62.55. Moreover, at the end of the last trading period, the closing price was at $84.30. * With a current rating of Buy, HC Wainwright & Co. initiated coverage on ClearSign Technologies Corp (NASDAQ: CLIR). The price target seems to have been set at $4.00 for ClearSign Technologies. ClearSign Technologies earned $0.05 in the second quarter, compared to $0.09 in the year-ago quarter. The stock has a 52-week-high of 4.11 and a 52-week-low of 0.35. At the end of the last trading period, ClearSign Technologies closed at $2.48. * RBC Capital initiated coverage on WAVE Life Sciences Ltd (NASDAQ: WVE) with a Sector Perform rating. The price target for WAVE Life Sciences is set to $13.00. In the second quarter, WAVE Life Sciences showed an EPS of $1.15, compared to $1.22 from the year-ago quarter. At the moment, the stock has a 52-week-high of 39.98 and a 52-week-low of 6.61. WAVE Life Sciences closed at $8.31 at the end of the last trading period. * With a current rating of Overweight, Cantor Fitzgerald initiated coverage on Stoke Therapeutics Inc (NASDAQ: STOK). The price target seems to have been set at $49.00 for Stoke Therapeutics. Stoke Therapeutics earned $0.39 in the second quarter, compared to $1.54 in the year-ago quarter. The current stock performance of Stoke Therapeutics shows a 52-week-high of 40.7 and a 52-week-low of 15.82. Moreover, at the end of the last trading period, the closing price was at $38.81. * JMP Securities initiated coverage on Shutterstock Inc (NYSE: SSTK) with a Market Outperform rating. The price target for Shutterstock is set to $72.00. For the second quarter, Shutterstock had an EPS of $0.62, compared to year-ago quarter EPS of $0.33. The stock has a 52-week-high of 62.58 and a 52-week-low of 28.76. At the end of the last trading period, Shutterstock closed at $60.33. * With a current rating of Outperform, Oppenheimer initiated coverage on Shake Shack Inc (NYSE: SHAK). The price target seems to have been set at $90.00 for Shake Shack. Shake Shack earned $0.45 in the second quarter, compared to $0.27 in the year-ago quarter. At the moment, the stock has a 52-week-high of 93.0355 and a 52-week-low of 30.01. Shake Shack closed at $72.56 at the end of the last trading period. * With a current rating of Overweight, Cantor Fitzgerald initiated coverage on Cassava Sciences Inc (NASDAQ: SAVA). The price target seems to have been set at $24.00 for Cassava Sciences. Cassava Sciences earned $0.05 in the second quarter, compared to $0.06 in the year-ago quarter. The stock has a 52-week-high of 12.68 and a 52-week-low of 1.05. At the end of the last trading period, Cassava Sciences closed at $8.83. * RBC Capital initiated coverage on uniQure NV (NASDAQ: QURE) with an Outperform rating. The price target for uniQure is set to $61.00. uniQure earned $0.96 in the second quarter, compared to $0.83 in the year-ago quarter. The current stock performance of uniQure shows a 52-week-high of 76.6869 and a 52-week-low of 34.38. Moreover, at the end of the last trading period, the closing price was at $41.26. * With a current rating of Buy, Guggenheim initiated coverage on Nevro Corp (NYSE: NVRO). The price target seems to have been set at $190.00 for Nevro. For the second quarter, Nevro had an EPS of $1.21, compared to year-ago quarter EPS of $0.91. The current stock performance of Nevro shows a 52-week-high of 166.29 and a 52-week-low of 65.05. Moreover, at the end of the last trading period, the closing price was at $162.39. * RBC Capital initiated coverage on MeiraGTx Holdings PLC (NASDAQ: MGTX) with an Outperform rating. The price target for MeiraGTx Hldgs is set to $27.00. MeiraGTx Hldgs earned $0.69 in the second quarter, compared to $0.63 in the year-ago quarter. The current stock performance of MeiraGTx Hldgs shows a 52-week-high of 22.32 and a 52-week-low of 8.82. Moreover, at the end of the last trading period, the closing price was at $13.09. * With a current rating of Buy, Stifel initiated coverage on Hycroft Mining Holding Corp (NASDAQ: HYMC). The price target seems to have been set at $15.00 for Hycroft Mining Holding. The current stock performance of Hycroft Mining Holding shows a 52-week-high of 16.1713 and a 52-week-low of 6.8. Moreover, at the end of the last trading period, the closing price was at $7.75. * Brookline Capital initiated coverage on electroCore Inc (NASDAQ: ECOR) with a Buy rating. The price target for electroCore is set to $5.00. In the second quarter, electroCore showed an EPS of $0.13, compared to $0.41 from the year-ago quarter. At the moment, the stock has a 52-week-high of 3.3 and a 52-week-low of 0.3201. electroCore closed at $1.57 at the end of the last trading period. * Brookline Capital initiated coverage on CTI BioPharma Corp (NASDAQ: CTIC) with a Buy rating. The price target for CTI BioPharma is set to $7.00. In the second quarter, CTI BioPharma showed an EPS of $0.19, compared to $0.19 from the year-ago quarter. The current stock performance of CTI BioPharma shows a 52-week-high of 3.68 and a 52-week-low of 0.62. Moreover, at the end of the last trading period, the closing price was at $3.34. * With a current rating of Sector Perform, RBC Capital initiated coverage on CRISPR Therapeutics AG (NASDAQ: CRSP). The price target seems to have been set at $110.00 for CRISPR Therapeutics. For the second quarter, CRISPR Therapeutics had an EPS of $1.30, compared to year-ago quarter EPS of $1.01. The current stock performance of CRISPR Therapeutics shows a 52-week-high of 111.9 and a 52-week-low of 32.3. Moreover, at the end of the last trading period, the closing price was at $90.16. * Wedbush initiated coverage on BigCommerce Holdings Inc (NASDAQ: BIGC) with a Neutral rating. The price target for BigCommerce Holdings is set to $90.00. Interestingly, in the second quarter, BigCommerce Holdings's EPS was $0.38. The current stock performance of BigCommerce Holdings shows a 52-week-high of 162.5 and a 52-week-low of 63.7716. Moreover, at the end of the last trading period, the closing price was at $89.95. * Guggenheim initiated coverage on Axonics Modulation Technologies Inc (NASDAQ: AXNX) with a Buy rating. The price target for Axonics Modulation Tech is set to $77.00. For the second quarter, Axonics Modulation Tech had an EPS of $0.54, compared to year-ago quarter EPS of $0.68. The stock has a 52-week-high of 52.1 and a 52-week-low of 15.25. At the end of the last trading period, Axonics Modulation Tech closed at $48.52. * Guggenheim initiated coverage on Axogen Inc (NASDAQ: AXGN) with a Buy rating. The price target for Axogen is set to $24.00. Axogen earned $0.15 in the second quarter, compared to $0.10 in the year-ago quarter. The stock has a 52-week-high of 18.84 and a 52-week-low of 7.16. At the end of the last trading period, Axogen closed at $13.35. * With a current rating of Outperform, RBC Capital initiated coverage on Allogene Therapeutics Inc (NASDAQ: ALLO). The price target seems to have been set at $55.00 for Allogene Therapeutics. In the second quarter, Allogene Therapeutics showed an EPS of $0.53, compared to $0.41 from the year-ago quarter. The current stock performance of Allogene Therapeutics shows a 52-week-high of 55.0 and a 52-week-low of 17.43. Moreover, at the end of the last trading period, the closing price was at $35.34. * RBC Capital initiated coverage on HealthEquity Inc (NASDAQ: HQY) with an Outperform rating. The price target for HealthEquity is set to $67.00. In the second quarter, HealthEquity showed an EPS of $0.42, compared to $0.45 from the year-ago quarter. At the moment, the stock has a 52-week-high of 88.78 and a 52-week-low of 34.4. HealthEquity closed at $55.14 at the end of the last trading period.See more from Benzinga * Options Trades For This Crazy Market: Get Benzinga Options to Follow High-Conviction Trade Ideas * Analyzing ACM Research's Unusual Options Activity * Unusual Options Activity Insight: Trinity Industries(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • GlobeNewswire

    Wave Life Sciences to Present at the Chardan Virtual 4th Annual Genetic Medicines Conference

    CAMBRIDGE, Mass., Sept. 28, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to present at the Chardan Virtual 4th Annual Genetic Medicines Conference on Tuesday, October 6, 2020 at 4:45 p.m. ET. A live webcast of the presentation will be available on the Investor Relations page of the Wave Life Sciences corporate website at http://ir.wavelifesciences.com. A replay of the presentation will be archived and available at that site for 90 days following the event.About Wave Life Sciences Wave Life Sciences (Nasdaq: WVE) is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company’s proprietary discovery and drug development platform that enables the precise design, optimization and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future. To find out more, please visit www.wavelifesciences.com and follow Wave on Twitter @WaveLifeSci.Investor Contacts: Kate Rausch 617-949-4827 krausch@wavelifesci.comGraham Morrell 781-686-9600 gmorrell@wavelifesci.comMedia Contact: Alicia Suter 617-949-4817 asuter@wavelifesci.com

  • Benzinga

    Unusual Options Activity Insight: WAVE Life Sciences

    Shares of WAVE Life Sciences (NASDAQ: WVE) saw some unusual options activity on Wednesday. Following the unusual option alert, the stock price moved down to $11.16. * Sentiment: BEARISH * Option Type: SWEEP * Trade Type: CALL * Expiration Date: 2020-10-16 * Strike Price: $20.00 * Volume: 295 * Open Interest: 2222Three Signs Of Unusual Options Activity Exceptionally large volume is one way options activity can be considered unusual. The volume of options activity refers to the number of shares contracts traded for a day. Open interest describes unsettled contracts that have been traded but not closed by a counter-party. In other words, for each contract buyer, there must be a seller. A purchased contract remains open until a seller closes it, and vice versa.When a contract has an expiration date in the distant future, it is generally another sign of unusual activity. Usually, additional time until a contract expires allows more opportunity for it to reach its strike price and grow its time value. Time value is important to consider because it represents the difference between the strike price and the value of the underlying asset."Out of the money" contracts are unusual because they are purchased with a strike price far from the underlying asset price. "Out of the money" occurs when the underlying price is under the strike price on a call option, or above the strike price on a put option. Buyers and sellers try to take advantage of a large profit margin in these instances because they are expecting the value of the underlying asset to change dramatically in the future.Understanding Sentiment Options are "bullish" when a call is purchased at/near ask price or a put is sold at/near bid price. Options are "bearish" when a call is sold at/near bid price or a put is bought at/near ask price.Although the activity is suggestive of these strategies, these observations are made without knowing the investor's true intentions when purchasing these options contracts. An observer cannot be sure if the bettor is playing the contract outright or if they're hedging a large underlying position in a common stock. For the latter case, the exposure a large investor has on their short position in common stock may be more meaningful than bullish options activity.Using These Options Strategies Unusual options activity is an advantageous strategy that may greatly reward an investor if they are highly skilled, but for the less experienced trader, it should remain as another tool to make an educated investment decision while taking other observations into account.For more information to understand options alerts, visit https://pro.benzinga.help/en/articles/1769505-how-do-i-understand-options-alertsSee more from Benzinga * WAVE Life Sciences: Q2 Earnings Insights * Earnings Scheduled For August 10, 2020(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.